Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic Leukemia

This study is currently recruiting participants.

Study NCT00450944 Information provided by National Cancer Institute (NCI)

First Received: March 20, 2007 Last Updated: February 6, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given